PAX Neuroscience Inc. Email Format

Biotechnology ResearchUnited States2-10 Employees

PAX Neuroscience, Inc. is a United States–based biotechnology research company focused on developing and commercializing blood-based tests for depression diagnosis and for predicting antidepressant response. Its work centers on identifying protein biomarkers through hypothesis-driven data sets, with early clinical results suggesting potential utility in clinical diagnostics for mood disorders. The company aims to provide objective tools that can assist clinicians in diagnosing depression and evaluating treatment effectiveness, addressing a need in mental health care for more precise, data-driven guidance.
Headquartered in the United States and operating within the biotechnology research sector, PAX Neuroscience positions itself at the intersection of clinical diagnostics and neuroscience. The organization has pursued recognition for its research activities, including an award from the Small Business Innovation Research program in 2017, reflecting engagement with federal support channels while continuing to develop its diagnostic offerings.

Sign up for free to view info

Company overview Employee directory